Finance

Lists
Why is VRCA up 4,19%?
Dive Deeper
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
3,73 $
+4,19%
(+0,15) 1D
14 հոկ, 11:27:16 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
3,54 $
High
3,81 $
Low
3,50 $
Mkt. cap
64,08 մլն
Avg. vol.
49,15 հզր
Volume
18,55 հզր
52-wk high
9,82 $
52-wk low
3,28 $
EPS
-1,67 $
Beta
1,60
Shares outstanding
17,18 մլն
No. of employees
76
Open
3,54 $
High
3,81 $
Low
3,50 $
Mkt. cap
64,08 մլն
Avg. vol.
49,15 հզր
Volume
18,55 հզր
52-wk high
9,82 $
52-wk low
3,28 $
EPS
-1,67 $
Beta
1,60
Shares outstanding
17,18 մլն
No. of employees
76
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees76
Founded2013
HeadquartersԱրևմտյան Չեստեր, Փենսիլվանիա, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current 3,73 $
20,00 $ (+436,19%)
Average
13,67 $ (+266,49%)
Lowest
9,00 $ (+141,29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
9,00 $
+141,3%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
12,00 $
+221,7%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
20,00 $
+436,2%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
17,00 $
+355,8%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
14,34 մլն
5,09 մլն
5,02 մլն
5,86 մլն
Cost of goods sold
3,31 մլն
3,92 մլն
4,75 մլն
6,91 մլն
Cost of revenue
3,31 մլն
3,92 մլն
4,75 մլն
6,91 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,40 մլն
8,12 մլն
9,99 մլն
10,35 մլն
Operating expense
9,40 մլն
8,12 մլն
9,99 մլն
10,35 մլն
Total operating expenses
12,72 մլն
12,04 մլն
14,74 մլն
17,26 մլն
Operating income
1,63 մլն
-6,95 մլն
-9,72 մլն
-11,40 մլն
Other non operating income
34,00 հզր
1,76 մլն
-8,00 հզր
-3,00 հզր
EBT including unusual items
-274,00 հզր
-8,07 մլն
-9,68 մլն
-13,15 մլն
EBT excluding unusual items
-274,00 հզր
-6,30 մլն
-9,68 մլն
-11,46 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-274,00 հզր
-8,07 մլն
-9,68 մլն
-13,15 մլն
Net profit margin
-1,91%
-158,56%
-192,75%
-224,38%
Earnings per share
0,13
-0,51
-0,45
-0,48
Interest and investment income
159,00 հզր
205,00 հզր
201,00 հզր
111,00 հզր
Interest expense
-2,09 մլն
-1,31 մլն
-160,00 հզր
-164,00 հզր
Net interest expenses
-1,94 մլն
-1,11 մլն
41,00 հզր
-53,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
1,74 մլն
-6,83 մլն
-9,60 մլն
-11,27 մլն
Gain or loss from assets sale
68,00 հզր
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps